Molecular remissions after non-myeloablative allografting for chronic myelocytic leukemia (CML).

被引：0
|
作者：
McSweeney, P
Niederwieser, D
Shizuru, J
Radich, J
Molina, A
Hegenbart, U
Chauncey, T
Sandmaier, B
Wolff, D
Blume, K
Storb, R
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Univ Leipzig, Leipzig, Germany
[4] Stanford Univ, Stanford, CA 94305 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3135
引用
收藏
页码：710A / 710A
页数：1
相关论文
共 50 条
  • [31] Non-myeloablative peripheral blood stem cell transplantation for chronic myelogenous leukemia.
    Sloand, EM
    Childs, RW
    Greene, A
    Phang, S
    Young, NS
    Barrett, J
    BLOOD, 2000, 96 (11) : 783A - 783A
  • [32] STUDY OF PROGNOSTIC PARAMETERS IN CHRONIC MYELOCYTIC-LEUKEMIA (CML)
    WEIL, M
    JACQUILLAT, C
    PEREIRA, NM
    GEMON, MF
    TANZER, J
    CHASTANG, C
    BERNARD, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 87 - 87
  • [33] CLINICAL IMPLICATIONS OF CYTOGENETIC VARIANTS IN CHRONIC MYELOCYTIC LEUKEMIA (CML)
    WHANGPENG, J
    CANELLOS, GP
    CARBONE, PP
    TJIO, JH
    BLOOD, 1968, 32 (05) : 755 - +
  • [34] CHANGES IN SURFACE OLIGOSACCHARIDES IN CHRONIC MYELOCYTIC-LEUKEMIA (CML)
    WHELTON, CH
    TAUB, RN
    BAKER, MA
    CLINICAL RESEARCH, 1982, 30 (03): : A692 - A692
  • [35] Regulatory T-cells and chronic GvHD after non-myeloablative conditioning
    Humblet-Baron, S.
    Castermans, E.
    Vanbellinghen, J-F.
    Hannon, M.
    Jacobs, N.
    Willems, E.
    Ormenese, S.
    Beguin, Y.
    Baron, F.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S284 - S284
  • [36] CHRONIC KIDNEY DISEASE AFTER NON-MYELOABLATIVE STEM CELL TRANSPLANTATION IN ADULTS
    Kersting, S.
    Verdonck, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 140 - 140
  • [37] THE CYTOGENETICS OF CHRONIC MYELOCYTIC-LEUKEMIA (CML) - CHRONIC PHASE AND BLASTIC CRISIS
    SANDBERG, AA
    CANCER GENETICS AND CYTOGENETICS, 1980, 1 (03) : 217 - 228
  • [38] Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting:: A prospective study
    Ruiz-Argüelles, GJ
    Gómez-Almaguer, D
    David-Gomez-Rangel, J
    Vela-Ojeda, J
    Cantú-Rodríguez, OG
    Jaime-Pérez, JC
    González-Llano, O
    Herrera-Garza, JL
    LEUKEMIA & LYMPHOMA, 2004, 45 (06) : 1191 - 1195
  • [39] Non-myeloablative allogeneic stem cell transplantation for the treatment of patients with chronic myeloid leukemia.
    Slavin, S
    Nagler, A
    Shapira, M
    Aker, M
    Or, R
    BLOOD, 2000, 96 (11) : 203A - 203A
  • [40] Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia
    Ruiz-Argüelles, GJ
    Gómez-Almaguer, D
    López-Martinez, B
    Cantú-Rodriguez, OG
    Jaime-Pérez, JC
    González-Llano, O
    HAEMATOLOGICA, 2002, 87 (08) : 894 - 896
12345